1. Home
  2. EEIQ vs MBIO Comparison

EEIQ vs MBIO Comparison

Compare EEIQ & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EpicQuest Education Group International Limited

EEIQ

EpicQuest Education Group International Limited

HOLD

Current Price

$2.30

Market Cap

3.8M

Sector

Real Estate

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.61

Market Cap

4.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EEIQ
MBIO
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
4.2M
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
EEIQ
MBIO
Price
$2.30
$0.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.2K
28.0K
Earning Date
01-28-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
98.99
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.52
52 Week High
$12.70
$1.88

Technical Indicators

Market Signals
Indicator
EEIQ
MBIO
Relative Strength Index (RSI) 55.37 46.70
Support Level $2.47 $0.55
Resistance Level $3.09 $0.66
Average True Range (ATR) 0.24 0.06
MACD 0.08 0.00
Stochastic Oscillator 76.91 55.56

Price Performance

Historical Comparison
EEIQ
MBIO

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S, Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. The Company's revenue is derived from foreign education programs, university education programs and student accommodation services.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: